Name | Number of supported studies | Average coverage | |
---|---|---|---|
GABAergic neuron | 3 studies | 36% ± 1% | |
glutamatergic neuron | 3 studies | 40% ± 3% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 28% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 434.83 | 2634 / 2642 | 100% | 9.47 | 705 / 705 |
breast | 100% | 618.32 | 459 / 459 | 99% | 9.39 | 1110 / 1118 |
thymus | 100% | 614.51 | 653 / 653 | 99% | 8.64 | 599 / 605 |
esophagus | 100% | 478.13 | 1444 / 1445 | 99% | 6.40 | 181 / 183 |
prostate | 100% | 527.36 | 245 / 245 | 99% | 6.12 | 495 / 502 |
bladder | 100% | 655.48 | 21 / 21 | 97% | 5.89 | 488 / 504 |
lung | 97% | 401.92 | 562 / 578 | 99% | 6.73 | 1140 / 1155 |
pancreas | 98% | 271.70 | 320 / 328 | 98% | 6.64 | 174 / 178 |
stomach | 100% | 374.02 | 358 / 359 | 95% | 5.71 | 271 / 286 |
intestine | 100% | 543.83 | 966 / 966 | 94% | 5.74 | 497 / 527 |
uterus | 100% | 652.34 | 170 / 170 | 94% | 5.55 | 431 / 459 |
kidney | 100% | 386.81 | 89 / 89 | 93% | 6.13 | 840 / 901 |
adrenal gland | 99% | 425.86 | 256 / 258 | 92% | 5.31 | 211 / 230 |
skin | 100% | 726.00 | 1808 / 1809 | 90% | 7.16 | 424 / 472 |
ovary | 100% | 527.02 | 180 / 180 | 81% | 3.31 | 347 / 430 |
liver | 100% | 298.61 | 226 / 226 | 78% | 3.14 | 315 / 406 |
adipose | 100% | 601.36 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 646.61 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 8.44 | 29 / 29 |
spleen | 100% | 583.44 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 3.02 | 1 / 1 |
muscle | 100% | 589.12 | 802 / 803 | 0% | 0 | 0 / 0 |
heart | 97% | 380.83 | 834 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 96% | 4.75 | 43 / 45 |
eye | 0% | 0 | 0 / 0 | 83% | 4.98 | 66 / 80 |
peripheral blood | 50% | 242.68 | 462 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0002098 | Biological process | tRNA wobble uridine modification |
GO_0006974 | Biological process | DNA damage response |
GO_0030488 | Biological process | tRNA methylation |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0000049 | Molecular function | tRNA binding |
GO_0016300 | Molecular function | tRNA (uridine) methyltransferase activity |
GO_0005506 | Molecular function | iron ion binding |
GO_0005515 | Molecular function | protein binding |
GO_0008270 | Molecular function | zinc ion binding |
GO_0008757 | Molecular function | S-adenosylmethionine-dependent methyltransferase activity |
GO_0106335 | Molecular function | tRNA (5-carboxymethyluridine(34)-5-O)-methyltransferase activity |
GO_0016706 | Molecular function | 2-oxoglutarate-dependent dioxygenase activity |
Gene name | ALKBH8 |
Protein name | AlkB homolog 8, tRNA methyltransferase Alkylated DNA repair protein alkB homolog 8 (Probable alpha-ketoglutarate-dependent dioxygenase ABH8) (S-adenosyl-L-methionine-dependent tRNA methyltransferase ABH8) (tRNA (carboxymethyluridine(34)-5-O)-methyltransferase ABH8) (EC 2.1.1.229) |
Synonyms | ABH8 |
Description | FUNCTION: Catalyzes the methylation of 5-carboxymethyl uridine to 5-methylcarboxymethyl uridine at the wobble position of the anticodon loop in tRNA via its methyltransferase domain . Catalyzes the last step in the formation of 5-methylcarboxymethyl uridine at the wobble position of the anticodon loop in target tRNA . Has a preference for tRNA(Arg) and tRNA(Glu), and does not bind tRNA(Lys). Binds tRNA and catalyzes the iron and alpha-ketoglutarate dependent hydroxylation of 5-methylcarboxymethyl uridine at the wobble position of the anticodon loop in tRNA via its dioxygenase domain, giving rise to 5-(S)-methoxycarbonylhydroxymethyluridine; has a preference for tRNA(Gly) . Required for normal survival after DNA damage . May inhibit apoptosis and promote cell survival and angiogenesis . . |
Accessions | ENST00000417449.6 [Q96BT7-1] Q96BT7 ENST00000428149.7 [Q96BT7-1] C9JQN2 ENST00000389568.7 [Q96BT7-1] ENST00000260318.6 [Q96BT7-2] ENST00000393100.3 ENST00000429370.5 [Q96BT7-3] |